"beta-Lactams" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
Descriptor ID |
D047090
|
MeSH Number(s) |
D02.065.589.099 D02.886.108 D03.633.100.300
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "beta-Lactams".
Below are MeSH descriptors whose meaning is more specific than "beta-Lactams".
This graph shows the total number of publications written about "beta-Lactams" by people in this website by year, and whether "beta-Lactams" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 1 | 2 |
2003 | 1 | 1 | 2 |
2005 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2013 | 1 | 2 | 3 |
2015 | 3 | 0 | 3 |
2016 | 1 | 1 | 2 |
2017 | 0 | 1 | 1 |
2018 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "beta-Lactams" by people in Profiles.
-
Lob SH, Hackel MA, Hoban DJ, Young K, Motyl MR, Sahm DF. Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016. Eur J Clin Microbiol Infect Dis. 2018 Aug; 37(8):1481-1489.
-
Hackel MA, Iaconis JP, Karlowsky JA, Sahm DF. Analysis of Potential ?-Lactam Surrogates To Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae. J Clin Microbiol. 2018 04; 56(4).
-
Wise MG, Horvath E, Young K, Sahm DF, Kazmierczak KM. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases. J Med Microbiol. 2018 Mar; 67(3):289-295.
-
Karlowsky JA, Hoban DJ, Hackel MA, Lob SH, Sahm DF. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. J Med Microbiol. 2017 Jan; 66(1):61-69.
-
Nichols WW, de Jonge BL, Kazmierczak KM, Karlowsky JA, Sahm DF. In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014). Antimicrob Agents Chemother. 2016 08; 60(8):4743-9.
-
King EA, Challa S, Curtin P, Bielory L. Penicillin skin testing in hospitalized patients with ?-lactam allergies: Effect on antibiotic selection and cost. Ann Allergy Asthma Immunol. 2016 07; 117(1):67-71.
-
Minneci PC, Deans KJ. Treatment of Uncomplicated Acute Appendicitis. JAMA. 2015 Oct 06; 314(13):1401-2.
-
Lob SH, Kazmierczak KM, Badal RE, Hackel MA, Bouchillon SK, Biedenbach DJ, Sahm DF. Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013. Antimicrob Agents Chemother. 2015; 59(6):3606-10.
-
Nair DR, Monteiro JM, Memmi G, Thanassi J, Pucci M, Schwartzman J, Pinho MG, Cheung AL. Characterization of a novel small molecule that potentiates ß-lactam activity against gram-positive and gram-negative pathogens. Antimicrob Agents Chemother. 2015 Apr; 59(4):1876-85.
-
Pucci MJ, Bush K. Investigational antimicrobial agents of 2013. Clin Microbiol Rev. 2013 Oct; 26(4):792-821.